14 Recruiting Non-Hodgkin Lymphoma Phase 1 Clinical Trials
Active phase 1 studies for non-hodgkin lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Non-Hodgkin Lymphoma studiesPhase 1 Studies for Non-Hodgkin Lymphoma
AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
📍 UCSF/Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program — San Francisco, California
View Study & Checklist ➔A Rollover Study of CC-122
📍 Local Institution - 100 — New York, New York
View Study & Checklist ➔A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
📍 Lucile Packard Children's Hospital /ID# 240854 — Palo Alto, California
View Study & Checklist ➔BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies
📍 Taussig Cancer Institute | Cleveland Clinic — Cleveland, Ohio
View Study & Checklist ➔Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
📍 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
📍 University of Colorado Hospital — Aurora, Colorado
View Study & Checklist ➔